JP6985752B2 - Kit for external skin preparation - Google Patents
Kit for external skin preparation Download PDFInfo
- Publication number
- JP6985752B2 JP6985752B2 JP2020024518A JP2020024518A JP6985752B2 JP 6985752 B2 JP6985752 B2 JP 6985752B2 JP 2020024518 A JP2020024518 A JP 2020024518A JP 2020024518 A JP2020024518 A JP 2020024518A JP 6985752 B2 JP6985752 B2 JP 6985752B2
- Authority
- JP
- Japan
- Prior art keywords
- agent
- acid
- skin
- kit
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims description 55
- 239000003795 chemical substances by application Substances 0.000 claims description 114
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 84
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 47
- 239000001569 carbon dioxide Substances 0.000 claims description 42
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 42
- 239000000203 mixture Substances 0.000 claims description 26
- 150000005846 sugar alcohols Polymers 0.000 claims description 26
- 239000000126 substance Substances 0.000 claims description 25
- 239000002253 acid Substances 0.000 claims description 24
- 239000003349 gelling agent Substances 0.000 claims description 21
- 239000002562 thickening agent Substances 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 4
- 210000003491 skin Anatomy 0.000 description 110
- 239000007789 gas Substances 0.000 description 27
- 150000003839 salts Chemical class 0.000 description 25
- 235000002639 sodium chloride Nutrition 0.000 description 25
- 238000002156 mixing Methods 0.000 description 22
- 230000000694 effects Effects 0.000 description 18
- 238000005259 measurement Methods 0.000 description 17
- 239000002537 cosmetic Substances 0.000 description 11
- 239000003814 drug Substances 0.000 description 11
- -1 martitol Chemical compound 0.000 description 11
- 241000196324 Embryophyta Species 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 239000004094 surface-active agent Substances 0.000 description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 7
- 229930182490 saponin Natural products 0.000 description 7
- 150000007949 saponins Chemical class 0.000 description 7
- 238000003860 storage Methods 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 238000005187 foaming Methods 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 229920000591 gum Polymers 0.000 description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 235000010443 alginic acid Nutrition 0.000 description 4
- 229920000615 alginic acid Polymers 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 description 4
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 235000010980 cellulose Nutrition 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 4
- 239000000825 pharmaceutical preparation Substances 0.000 description 4
- 229940127557 pharmaceutical product Drugs 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 229920001059 synthetic polymer Polymers 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 240000004670 Glycyrrhiza echinata Species 0.000 description 3
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- 206010042496 Sunburn Diseases 0.000 description 3
- 235000010489 acacia gum Nutrition 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 229940050528 albumin Drugs 0.000 description 3
- 239000000783 alginic acid Substances 0.000 description 3
- 229960001126 alginic acid Drugs 0.000 description 3
- 150000004781 alginic acids Chemical class 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 238000001879 gelation Methods 0.000 description 3
- 229940010454 licorice Drugs 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- 235000010987 pectin Nutrition 0.000 description 3
- 239000001814 pectin Substances 0.000 description 3
- 229920001277 pectin Polymers 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- 229920000057 Mannan Polymers 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 241001093760 Sapindaceae Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 240000004584 Tamarindus indica Species 0.000 description 2
- 235000004298 Tamarindus indica Nutrition 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 229940105990 diglycerin Drugs 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- ROBFUDYVXSDBQM-UHFFFAOYSA-N hydroxymalonic acid Chemical compound OC(=O)C(O)C(O)=O ROBFUDYVXSDBQM-UHFFFAOYSA-N 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 239000004584 polyacrylic acid Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 150000003408 sphingolipids Chemical class 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- VBSTXRUAXCTZBQ-UHFFFAOYSA-N 1-hexyl-4-phenylpiperazine Chemical compound C1CN(CCCCCC)CCN1C1=CC=CC=C1 VBSTXRUAXCTZBQ-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- FEWFXBUNENSNBQ-UHFFFAOYSA-N 2-hydroxyacrylic acid Chemical compound OC(=C)C(O)=O FEWFXBUNENSNBQ-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 240000004270 Colocasia esculenta var. antiquorum Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 108010022355 Fibroins Proteins 0.000 description 1
- NGGYSPUAKQMTNP-UHFFFAOYSA-N Glabrene Chemical compound C1=C(O)C=C2OCC(C3=C4OC(C=CC4=C(O)C=C3)(C)C)=CC2=C1 NGGYSPUAKQMTNP-UHFFFAOYSA-N 0.000 description 1
- KKLOCFOZPFGVBB-UHFFFAOYSA-N Glabrene Natural products C1=C(O)C=C2OCC(C3=CC=C4OC(C=CC4=C3O)(C)C)=CC2=C1 KKLOCFOZPFGVBB-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 241000238814 Orthoptera Species 0.000 description 1
- 235000006089 Phaseolus angularis Nutrition 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241000580955 Sapindus mukorossi Species 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 108010013296 Sericins Proteins 0.000 description 1
- 244000046101 Sophora japonica Species 0.000 description 1
- 235000010586 Sophora japonica Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- JACRWUWPXAESPB-QMMMGPOBSA-N Tropic acid Natural products OC[C@H](C(O)=O)C1=CC=CC=C1 JACRWUWPXAESPB-QMMMGPOBSA-N 0.000 description 1
- 240000007098 Vigna angularis Species 0.000 description 1
- 235000010711 Vigna angularis Nutrition 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229920002000 Xyloglucan Polymers 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- ZMCUDHNSHCRDBT-UHFFFAOYSA-M caesium bicarbonate Chemical compound [Cs+].OC([O-])=O ZMCUDHNSHCRDBT-UHFFFAOYSA-M 0.000 description 1
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 description 1
- 229910000020 calcium bicarbonate Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 244000013123 dwarf bean Species 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- LBQIJVLKGVZRIW-ZDUSSCGKSA-N glabridin Chemical compound C1([C@H]2CC3=CC=C4OC(C=CC4=C3OC2)(C)C)=CC=C(O)C=C1O LBQIJVLKGVZRIW-ZDUSSCGKSA-N 0.000 description 1
- 229940093767 glabridin Drugs 0.000 description 1
- PMPYOYXFIHXBJI-ZDUSSCGKSA-N glabridin Natural products C1([C@H]2CC=3C=CC4=C(C=3OC2)CCC(O4)(C)C)=CC=C(O)C=C1O PMPYOYXFIHXBJI-ZDUSSCGKSA-N 0.000 description 1
- LBQIJVLKGVZRIW-UHFFFAOYSA-N glabridine Natural products C1OC2=C3C=CC(C)(C)OC3=CC=C2CC1C1=CC=C(O)C=C1O LBQIJVLKGVZRIW-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940070818 glycyrrhizate Drugs 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229910052622 kaolinite Inorganic materials 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229910000032 lithium hydrogen carbonate Inorganic materials 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- HQRPHMAXFVUBJX-UHFFFAOYSA-M lithium;hydrogen carbonate Chemical compound [Li+].OC([O-])=O HQRPHMAXFVUBJX-UHFFFAOYSA-M 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- QWDJLDTYWNBUKE-UHFFFAOYSA-L magnesium bicarbonate Chemical compound [Mg+2].OC([O-])=O.OC([O-])=O QWDJLDTYWNBUKE-UHFFFAOYSA-L 0.000 description 1
- 229910000022 magnesium bicarbonate Inorganic materials 0.000 description 1
- 239000002370 magnesium bicarbonate Substances 0.000 description 1
- 235000014824 magnesium bicarbonate Nutrition 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- HYYBABOKPJLUIN-UHFFFAOYSA-N mefenamic acid Chemical compound CC1=CC=CC(NC=2C(=CC=CC=2)C(O)=O)=C1C HYYBABOKPJLUIN-UHFFFAOYSA-N 0.000 description 1
- 229960003464 mefenamic acid Drugs 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 229960002895 phenylbutazone Drugs 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 229940048730 senega Drugs 0.000 description 1
- 230000008326 skin blood flow Effects 0.000 description 1
- 229910021647 smectite Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 229910000031 sodium sesquicarbonate Inorganic materials 0.000 description 1
- 235000018341 sodium sesquicarbonate Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- WCTAGTRAWPDFQO-UHFFFAOYSA-K trisodium;hydrogen carbonate;carbonate Chemical compound [Na+].[Na+].[Na+].OC([O-])=O.[O-]C([O-])=O WCTAGTRAWPDFQO-UHFFFAOYSA-K 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
本発明は、発泡性皮膚外用剤を得るためのキットであって、第一剤が炭酸ガス発生物質、ゲル化剤及び水を含有する組成物であり、第二剤が酸、水及び多価アルコールを含有する組成物であることを特徴とするキットに関する。 The present invention is a kit for obtaining an effervescent skin external preparation, in which the first agent is a composition containing a carbon dioxide gas generating substance, a gelling agent and water, and the second agent is an acid, water and polyvalent. The present invention relates to a kit characterized by being a composition containing alcohol.
炭酸ガスが皮膚に作用すると皮膚の血行促進効果があることから、種々の炭酸ガスを利用した皮膚外用剤が提案されている。これらの多くは、酸と炭酸ガス発生物質の反応により、炭酸ガスを発生させるものである。例えば、発生した炭酸ガスの効果を保持するために、酸、水及び増粘剤を含む含水粘性組成物と、固体状の炭酸ガス発生物質を使用直前に混合して使用する方法が提案されている(特許文献1)。また、加水分解されて酸を生じる物質、炭酸塩、増粘剤、カルシウムイオンによってゲル化するゲル化剤、及び水不溶性又は水難溶性カルシウム塩を含む粒状物に、使用直前に水と混合して使用する方法が提案されている(特許文献2)。また、キシログルカンと多価アルコールによりゲル化する組成物を用いる方法が提案されている。 Since carbon dioxide has an effect of promoting blood circulation in the skin when it acts on the skin, various external skin preparations using carbon dioxide have been proposed. Most of these generate carbon dioxide gas by the reaction of acid and carbon dioxide gas generating substance. For example, in order to maintain the effect of the generated carbon dioxide gas, a method of mixing and using a water-containing viscous composition containing an acid, water and a thickener and a solid carbon dioxide gas generating substance immediately before use has been proposed. (Patent Document 1). In addition, a granular substance containing a substance that is hydrolyzed to produce an acid, a carbonate, a thickener, a gelling agent that gels with calcium ions, and a water-insoluble or sparingly water-soluble calcium salt is mixed with water immediately before use. A method to be used has been proposed (Patent Document 2). In addition, a method using a composition that gels with xyloglucan and a polyhydric alcohol has been proposed.
しかしながら、特許文献1に記載の方法で炭酸ガスを発生させる場合、含水粘性組成物と固体状の炭酸ガス発生物質との均一な混合は困難であり、炭酸ガスによる発泡にムラが生じやすく、発泡が開始するまでに時間がかかってしまう。また、特許文献2に記載の方法では、水の計量に手間がかかるため、使用者にとっては面倒であり、また、使用する水の品質により使用時の粘度や炭酸ガス発生量が一定にならず、使用毎に効果が異なってしまう。また、特許文献3に記載の方法では、使用後の除去は容易であるものの、組成物の粘性が高い上にゲル化しやすい設計であるため、炭酸ガスの効果が得られにくいものであった。 However, when carbon dioxide gas is generated by the method described in Patent Document 1, it is difficult to uniformly mix the hydrous viscous composition and the solid carbon dioxide gas generating substance, and foaming due to carbon dioxide gas tends to be uneven, resulting in foaming. It takes time to start. Further, the method described in Patent Document 2 is troublesome for the user because it takes time and effort to measure water, and the viscosity and the amount of carbon dioxide gas generated at the time of use are not constant depending on the quality of the water used. , The effect will be different depending on the use. Further, in the method described in Patent Document 3, although it is easy to remove after use, it is difficult to obtain the effect of carbon dioxide gas because the composition has a high viscosity and is designed to easily gel.
本発明は、前記事情に鑑みなされたものであり、混合時に均一に混ざりやすく、炭酸ガスがムラなく発生し、一定品質の発泡性皮膚外用剤を得るためのキットの提供を目的とする。 The present invention has been made in view of the above circumstances, and an object of the present invention is to provide a kit for obtaining an effervescent skin external preparation of constant quality, which is easily mixed uniformly at the time of mixing, carbon dioxide gas is generated evenly.
本発明は、以下の発泡性皮膚外用剤を得るためのキット(以下、本発明のキットとも言う)を提供するものである。
<1>発泡性皮膚外用剤を得るためのキットであって、炭酸ガス発生物質、酸、ゲル化剤、多価アルコール及び水を含有し、以下の(A)又は(B)のいずれかの形態であることを特徴とするキット。
(A)第一剤が炭酸ガス発生物質、ゲル化剤及び水を含有する組成物であり、第二剤が酸、水及び多価アルコールを含有する組成物。
(B)第一剤が酸、ゲル化剤及び水を含有する組成物であり、第二剤が炭酸ガス発生物質、水及び多価アルコールを含有する組成物。
<2>第一剤のゲル化剤がタマリンドガムであることを特徴とする、<1>に記載のキット。
<3>第二剤が、液状の組成物であることを特徴とする、<1>又は<2>のいずれかに記載のキット。
<4>第一剤の粘度が、100mPa・s以上であることを特徴とする、<1>〜<3>のいずれかに記載のキット。
<5>第二剤の粘度が、20,000mPa・s以下であることを特徴とする、<1>〜<4>のいずれかに記載のキット。
The present invention provides a kit for obtaining the following effervescent skin external preparation (hereinafter, also referred to as the kit of the present invention).
<1> A kit for obtaining an effervescent skin external preparation, which contains a carbon dioxide gas generating substance, an acid, a gelling agent, a polyhydric alcohol and water, and is either (A) or (B) below. A kit characterized by being in the form.
(A) A composition in which the first agent contains a carbon dioxide gas generating substance, a gelling agent and water, and the second agent contains an acid, water and a polyhydric alcohol.
(B) A composition in which the first agent contains an acid, a gelling agent and water, and the second agent contains a carbon dioxide gas generating substance, water and a polyhydric alcohol.
<2> The kit according to <1>, wherein the gelling agent of the first agent is tamarind gum.
<3> The kit according to any one of <1> or <2>, wherein the second agent is a liquid composition.
<4> The kit according to any one of <1> to <3>, wherein the viscosity of the first agent is 100 mPa · s or more.
<5> The kit according to any one of <1> to <4>, wherein the viscosity of the second agent is 20,000 mPa · s or less.
本発明によれば、使用者が混合時に均一に混ぜやすく、炭酸ガスがムラなくすぐに発生し、炭酸ガスの効果を得やすく、使用後に除去しやすいキットを提供することができる。また、本発明のキットを用いて得られた発泡性皮膚外用剤をパック剤として使用することで、肌状態改善効果、特に、短時間での美白効果を得ることができる。 According to the present invention, it is possible to provide a kit that is easy for the user to mix uniformly at the time of mixing, carbon dioxide gas is generated evenly and immediately, the effect of carbon dioxide gas is easily obtained, and it is easy to remove after use. Further, by using the effervescent skin external preparation obtained by using the kit of the present invention as a pack agent, an effect of improving the skin condition, particularly a whitening effect in a short time can be obtained.
本発明は、発泡性皮膚外用剤を得るためのキットであって、炭酸ガス発生物質、酸、ゲル化剤、多価アルコール及び水を含有し、以下の(A)又は(B)のいずれかの形態であることを特徴とするキットに関する。
(A)第一剤が炭酸ガス発生物質、ゲル化剤及び水を含有する組成物であり、第二剤が酸、水及び多価アルコールを含有する組成物。
(B)第一剤が酸、ゲル化剤及び水を含有する組成物であり、第二剤が炭酸ガス発生物質、水及び多価アルコールを含有する組成物。
The present invention is a kit for obtaining an effervescent skin external preparation, which contains a carbon dioxide gas generating substance, an acid, a gelling agent, a polyhydric alcohol and water, and is either (A) or (B) below. The present invention relates to a kit characterized by being in the form of.
(A) A composition in which the first agent contains a carbon dioxide gas generating substance, a gelling agent and water, and the second agent contains an acid, water and a polyhydric alcohol.
(B) A composition in which the first agent contains an acid, a gelling agent and water, and the second agent contains a carbon dioxide gas generating substance, water and a polyhydric alcohol.
そして、本発明のキットにおいては、使用者が、使用時に、前記第一剤と第二剤とを適宜混合することにより炭酸ガス発生による発泡を生じせしめ、皮膚に塗布して用いることができる。本発明のキットは、第一剤と第二剤に分けることにより保存安定性が良く、かつ、使用者が使用時に取り扱いやすいという特徴を有する。また、ゲル化剤と多価アルコールを含有することにより、脱水作用によるゲル化剤の凝集、多価アルコールとゲル化剤との水素結合による高次のネットワーク形成により、発泡性皮膚外用剤はゲル化するため、使用後に容易に除去することが可能である。以下、本発明のキット及び本発明のキットを用いて得られる発泡性皮膚外用剤に含まれる各構成成分及びその製法について説明する。 Then, in the kit of the present invention, the user can appropriately mix the first agent and the second agent at the time of use to cause foaming due to the generation of carbon dioxide gas, and apply the agent to the skin for use. The kit of the present invention has the characteristics that the storage stability is good and the user can easily handle it at the time of use by dividing it into the first agent and the second agent. In addition, by containing the gelling agent and the polyhydric alcohol, the effervescent skin external preparation can be gelled by the aggregation of the gelling agent by the dehydration action and the formation of a higher-order network by the hydrogen bond between the polyhydric alcohol and the gelling agent. Therefore, it can be easily removed after use. Hereinafter, each component contained in the kit of the present invention and the effervescent skin external preparation obtained by using the kit of the present invention and a method for producing the same will be described.
本発明のキットには、炭酸ガス発生物質、酸、ゲル化剤、多価アルコール及び水を含有する。本発明の詳細について以下に説明する。 The kit of the present invention contains a carbon dioxide generating substance, an acid, a gelling agent, a polyhydric alcohol and water. Details of the present invention will be described below.
≪炭酸ガス発生物質≫
本発明に用いられる炭酸ガス発生物質としては、様々なものが特に限定されることなく使用できる。また、使用する炭酸ガス発生物質は、固体状が好ましく、水又は保湿剤への溶解性の観点から、顆粒状、細粒状、粉末状がより好ましい。
≪Carbon dioxide generating substances≫
As the carbon dioxide generating substance used in the present invention, various substances can be used without particular limitation. The carbon dioxide gas generating substance to be used is preferably in the form of a solid, and more preferably in the form of granules, fine granules or powder from the viewpoint of solubility in water or a moisturizer.
前記炭酸ガス発生物質として、炭酸ナトリウム、炭酸カルシウム、炭酸カリウム、炭酸マグネシウム、セスキ炭酸ナトリウム等の炭酸塩、炭酸水素アンモニウム、炭酸水素カリウム、炭酸水素ナトリウム、炭酸水素リチウム、炭酸水素セシウム、炭酸水素マグネシウム、炭酸水素カルシウム等の炭酸水素塩等が挙げられ、これらの1種又は2種以上が用いられる。これらのうち、炭酸水素塩が好ましく使用でき、程よい発泡力を実現することができる点で炭酸水素ナトリウムがより好ましい。 As the carbon dioxide generating substance, carbonates such as sodium carbonate, calcium carbonate, potassium carbonate, magnesium carbonate, sodium sesquicarbonate, ammonium hydrogencarbonate, potassium hydrogencarbonate, sodium hydrogencarbonate, lithium hydrogencarbonate, cesium hydrogencarbonate, magnesium hydrogencarbonate , Bicarbonates such as calcium hydrogen carbonate and the like, and one or more of these are used. Of these, sodium hydrogencarbonate is more preferable in that hydrogencarbonate can be preferably used and moderate foaming power can be realized.
前記炭酸ガス発生物質の配合量は、第一剤又は第二剤中に0.05〜40質量%が好ましく、0.1〜35質量%がより好ましく、0.5〜30質量%が特に好ましい。また、発泡性皮膚外用剤中に0.01〜30質量%が好ましく、0.05〜25質量%がより好ましく、0.1〜20質量%が特に好ましい。 The blending amount of the carbon dioxide generating substance is preferably 0.05 to 40% by mass, more preferably 0.1 to 35% by mass, and particularly preferably 0.5 to 30% by mass in the first agent or the second agent. .. Further, 0.01 to 30% by mass is preferable, 0.05 to 25% by mass is more preferable, and 0.1 to 20% by mass is particularly preferable in the effervescent skin external preparation.
≪酸≫
本発明に用いられる酸としては、有機酸、無機酸のいずれでもよく、これらの1種又は2種以上が用いられる。
≪Acid≫
The acid used in the present invention may be either an organic acid or an inorganic acid, and one or more of these may be used.
有機酸としては、ギ酸、酢酸、プロピオン酸、酪酸、吉草酸等の直鎖脂肪酸又はその塩類、シュウ酸、マロン酸、コハク酸、グルタル酸、アジピン酸、ピメリン酸、フマル酸、マレイン酸、フタル酸、イソフタル酸、テレフタル酸等のジカルボン酸又はその塩類、グルタミン酸、アスパラギン酸等の酸性アミノ酸又はその塩類、グリコール酸、リンゴ酸、酒石酸、クエン酸、乳酸、ヒドロキシアクリル酸、α−オキシ酪酸、グリセリン酸、タルトロン酸、サリチル酸、没食子酸、トロパ酸、アスコルビン酸、グルコン酸等のオキシ酸又はその塩類等が挙げられ、無機酸としては、リン酸、亜硫酸等の無機酸又はその塩類が挙げられ、これらの1種又は2種以上を用いることができる。なかでも、安全性、第二剤への溶解性の観点から、クエン酸又はその塩類、アスコルビン酸又はその塩類、リンゴ酸又はその塩類、コハク酸又はその塩類が好ましく、クエン酸又はその塩類、アスコルビン酸又はその塩類がより好ましい。 Organic acids include linear fatty acids such as formic acid, acetic acid, propionic acid, butyric acid and valeric acid or salts thereof, oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, fumaric acid, maleic acid and phthalic acid. Dicarboxylic acids such as acid, isophthalic acid and terephthalic acid or salts thereof, acidic amino acids such as glutamic acid and aspartic acid or salts thereof, glycolic acid, malic acid, tartrate acid, citric acid, lactic acid, hydroxyacrylic acid, α-oxybutyric acid, glycerin Examples thereof include oxy acids such as acids, tartronic acid, salicylic acid, gallic acid, tropic acid, ascorbic acid and gluconic acid or salts thereof, and examples of the inorganic acid include inorganic acids such as phosphoric acid and sulfite or salts thereof. One or more of these can be used. Among them, citric acid or its salts, ascorbic acid or its salts, malic acid or its salts, succinic acid or its salts are preferable, and citric acid or its salts and ascorbin are preferable from the viewpoint of safety and solubility in a second agent. Acids or salts thereof are more preferred.
前記酸の配合量は、第一剤又は第二剤中に0.01〜40質量%が好ましく、0.05〜35質量%がより好ましく、0.1〜30質量%が特に好ましい。また、発泡性皮膚外用剤中に0.001〜30質量%が好ましく、0.005〜25質量%がより好ましく、0.01〜20質量%が特に好ましい。 The blending amount of the acid is preferably 0.01 to 40% by mass, more preferably 0.05 to 35% by mass, and particularly preferably 0.1 to 30% by mass in the first agent or the second agent. Further, 0.001 to 30% by mass is preferable, 0.005 to 25% by mass is more preferable, and 0.01 to 20% by mass is particularly preferable in the effervescent skin external preparation.
≪ゲル化剤≫
本発明に使用されるゲル化剤は、多価アルコールと反応してゲル化する性質を有する。使用できるゲル化剤の具体例としては、タマリンドガムが挙げられる。
≪Gelling agent≫
The gelling agent used in the present invention has a property of reacting with a polyhydric alcohol to gel. Specific examples of gelling agents that can be used include tamarind gum.
前記ゲル化剤の配合量は、第一剤中に0.01〜40質量%が好ましく、0.05〜35質量%がより好ましく、0.1〜30質量%が特に好ましい。また、発泡性皮膚外用剤中に0.001〜30質量%が好ましく、0.005〜25質量%がより好ましく、0.01〜20質量%が特に好ましい。 The blending amount of the gelling agent is preferably 0.01 to 40% by mass, more preferably 0.05 to 35% by mass, and particularly preferably 0.1 to 30% by mass in the first agent. Further, 0.001 to 30% by mass is preferable, 0.005 to 25% by mass is more preferable, and 0.01 to 20% by mass is particularly preferable in the effervescent skin external preparation.
≪多価アルコール≫
本発明に用いる多価アルコールとしては、1分子中に2個以上のヒドロキシ基を有するものであり、通常化粧品、外用医薬品、医薬部外品等で使用できるものであれば特に限定されず、例えばグリセリン、ジグリセリン、トリグリセリン、テトラグリセリン等のポリグリセリン、エチレングリコール、1,3−ブチレングリコール、1,4−ブチレングリコール、プロピレングリコール、ジプロピレングリコール、ポリエチレングリコール、1,3−プロパンジオール、エリトリトール、マルチトール、マンニトール、ソルビトール、キシリトール等の糖アルコール、ポリグリセリン誘導体、スクロース、トレハロース等の糖類等が挙げられる。前記多価アルコールのうち、第二剤の保存安定性や製造コスト、使用時の皮膚への刺激緩和の観点から少なくとも1種の多価アルコールを使用することが好ましく、2種類以上を使用することが好ましい。特にグリセリン、ジグリセリン、1,3−ブチレングリコール、1,4−ブチレングリコール、ジプロピレングリコール、ポリエチレングリコールのうち少なくとも1種を使用することが好ましい。
≪Multivalent alcohol≫
The polyhydric alcohol used in the present invention is not particularly limited as long as it has two or more hydroxy groups in one molecule and can be used in ordinary cosmetics, external pharmaceuticals, non-pharmaceutical products, etc., for example. Polyglycerin such as glycerin, diglycerin, triglycerin, tetraglycerin, ethylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, propylene glycol, dipropylene glycol, polyethylene glycol, 1,3-propanediol, erythritol , Sugar alcohols such as martitol, mannitol, sorbitol, xylitol, polyglycerin derivatives, saccharides such as sucrose and trehalose, and the like. Of the above-mentioned polyhydric alcohols, it is preferable to use at least one kind of polyhydric alcohol from the viewpoint of storage stability of the second agent, manufacturing cost, and alleviation of irritation to the skin at the time of use, and two or more kinds should be used. Is preferable. In particular, it is preferable to use at least one of glycerin, diglycerin, 1,3-butylene glycol, 1,4-butylene glycol, dipropylene glycol, and polyethylene glycol.
前記多価アルコールの配合量は、第二剤中に10質量%以上であれば良く、30質量%以上が好ましく、30〜99質量%がより好ましい。また、多価アルコールは第一剤にも配合することが好ましく、配合する場合は、1質量%以上であれば良く、3〜50質量%が好ましく、5〜30質量%がより好ましい。さらに、多価アルコールの配合量は発泡性皮膚外用剤中に5質量%以上であれば良く、10〜90質量%が好ましく、20〜80質量%以上がより好ましいく、30〜70質量%が特に好ましい。発泡性皮膚外用剤中の多価アルコールの含有量が5質量%より少ないと、使用時にゲル化しにくくなるだけでなく、拡散水分量や弾力等の肌への効果が低くなり、使用時の取り扱いやすさ、例えば混ぜやすさや塗りやすさ、垂れにくさ、除去のしやすさが悪くなる。 The blending amount of the polyhydric alcohol may be 10% by mass or more, preferably 30% by mass or more, and more preferably 30 to 99% by mass in the second agent. Further, the polyhydric alcohol is preferably blended in the first agent, and when blended, it may be 1% by mass or more, preferably 3 to 50% by mass, and more preferably 5 to 30% by mass. Further, the blending amount of the polyhydric alcohol may be 5% by mass or more in the effervescent skin external preparation, preferably 10 to 90% by mass, more preferably 20 to 80% by mass or more, and 30 to 70% by mass. Especially preferable. If the content of polyhydric alcohol in the effervescent skin external preparation is less than 5% by mass, not only is it difficult to gel during use, but also the effects on the skin such as the amount of diffused water and elasticity are reduced, and handling during use. Ease of mixing, for example, ease of mixing, ease of application, difficulty in dripping, and ease of removal are deteriorated.
≪水≫
本発明に使用される水は、化粧品、外用医薬品、医薬部外品等で使用できる水を使用することができるが、精製水、蒸留水、膜濾過水、イオン交換水、が好ましい。本発明においては、第一剤、第二剤それぞれ0.1質量%以上配合していれば良く、好ましくは0.5質量%以上である。また、水は発泡性皮膚外用剤中に5質量%以上配合していれば良く、10〜85質量%が好ましく、20〜80質量%がより好ましい。水が5質量%未満であると、混合した際に炭酸ガスが発生しにくくなる、炭酸ガスの発生量が減少する等の問題が生じてしまい、その結果、十分な血行促進作用を得ることができなくなる。
≪Water≫
As the water used in the present invention, water that can be used in cosmetics, external medicines, non-pharmaceutical products, etc. can be used, but purified water, distilled water, membrane filtered water, ion-exchanged water, etc. are preferable. In the present invention, each of the first agent and the second agent may be blended in an amount of 0.1% by mass or more, preferably 0.5% by mass or more. Further, the water may be blended in an effervescent skin external preparation in an amount of 5% by mass or more, preferably 10 to 85% by mass, more preferably 20 to 80% by mass. If the amount of water is less than 5% by mass, problems such as difficulty in generating carbon dioxide gas when mixed and a decrease in the amount of carbon dioxide gas generated may occur, and as a result, a sufficient blood circulation promoting action may be obtained. become unable.
本願発明において、発泡性皮膚外用剤中の多価アルコール:水の配合比(質量比)は特に限定されないが、好ましくは1:0.05〜20であり、より好ましくは1:0.1〜10であり、特に好ましくは1:0.5〜5である。多価アルコールに対して水の配合比が0.05未満であると、第一剤、第二剤中での炭酸ガス発生物質、酸、増粘剤の溶解に時間がかかるため、製造効率が悪くなるのみでなく、第一剤と第二剤の反応による炭酸ガス発生速度が著しく低下してしまう。しかも、第一剤と第二剤の混合後のゲル化速度が速いため、炭酸ガスが発生する前にゲル化が起こってしまい、血行促進作用等の炭酸ガスによる効果を得にくくなる。また、多価アルコールに対して水が20より多いと、第一剤と第二剤との混合後のゲル化が著しく遅くなるため、使用後に剥がしづらくなり、使用者にとって使用しづらいものとなる。 In the present invention, the compounding ratio (mass ratio) of polyvalent alcohol: water in the effervescent skin external preparation is not particularly limited, but is preferably 1: 0.05 to 20, more preferably 1: 0.1 to 1. It is 10, and particularly preferably 1: 0.5 to 5. If the mixing ratio of water to the polyhydric alcohol is less than 0.05, it takes time to dissolve the carbon dioxide generating substance, acid, and thickener in the first agent and the second agent, resulting in higher production efficiency. Not only is it worse, but the rate of carbon dioxide generation due to the reaction between the first agent and the second agent is significantly reduced. Moreover, since the gelation rate after mixing the first agent and the second agent is high, gelation occurs before carbon dioxide gas is generated, and it becomes difficult to obtain the effect of carbon dioxide gas such as blood circulation promoting action. In addition, if the amount of water is more than 20 with respect to the polyhydric alcohol, gelation after mixing the first agent and the second agent is remarkably slowed down, which makes it difficult to peel off after use and makes it difficult for the user to use. ..
本発明の第一剤は粘度が高いことが好ましい。具体的には、25℃における粘度が、好ましくは100mPa・s以上であり、より好ましくは500mPa・s以上であり、特に好ましくは1,000mPa・s以上である。本発明において、第一剤の粘度が100mPa・s未満の場合、第二剤との混合後の組成物が垂れやすくなってしまい、使用しにくいのみでなく。皮膚外用剤の効果を得られにくくなる。 The first agent of the present invention preferably has a high viscosity. Specifically, the viscosity at 25 ° C. is preferably 100 mPa · s or more, more preferably 500 mPa · s or more, and particularly preferably 1,000 mPa · s or more. In the present invention, when the viscosity of the first agent is less than 100 mPa · s, the composition after mixing with the second agent tends to drip, which is not only difficult to use. It becomes difficult to obtain the effect of the external skin preparation.
本発明の第二剤は粘度が低いことがより好ましい。具体的には、25℃における粘度が、好ましくは20,000mPa・s以下であり、より好ましくは10,000mPa・s以下であり、特に好ましくは5,000mPa・s以下である。また、本発明の第二剤は、液状であることが好ましく、増粘剤を含有する場合は0.2質量%未満であることが好ましく、実質的に増粘剤を含まないことがより好ましい。ここで、実質的に増粘剤を含まないとは、後述する増粘剤を、第二剤に含まないことを言う。本発明において、第二剤の粘度が20,000mPa・sを超える場合、参考例1及び2から明らかな通り、第一剤との混合時に混ぜにくいため、混合のムラが生じるため、炭酸ガスによる発泡にムラが発生しやすくなる。 It is more preferable that the second agent of the present invention has a low viscosity. Specifically, the viscosity at 25 ° C. is preferably 20,000 mPa · s or less, more preferably 10,000 mPa · s or less, and particularly preferably 5,000 mPa · s or less. Further, the second agent of the present invention is preferably liquid, preferably less than 0.2% by mass when containing a thickener, and more preferably substantially free of a thickener. .. Here, "substantially free of thickener" means that the thickener described later is not contained in the second agent. In the present invention, when the viscosity of the second agent exceeds 20,000 mPa · s, as is clear from Reference Examples 1 and 2, it is difficult to mix the mixture with the first agent, resulting in uneven mixing. Unevenness is likely to occur in foaming.
本発明においては、第一剤の粘度を100mPa・s以上、かつ、第二剤の粘度を20,000mPa・s以下とすることが好ましい。より好ましくは、第一剤の粘度が500mPa・s以上、かつ、第二剤の粘度が10,000mPa・s以下であり、より好ましくは第一剤の粘度が1,000mPa・s以上、かつ、第二剤の粘度が5,000mPa・s以下である。第一剤、第二剤の粘度を前記の範囲にすることにより、発泡性皮膚外用剤のゲル化能と炭酸ガスによる肌への効果をバランス良く両立させることが可能となる。特に、後述する実施例から明らかな通り、肌のしっとり感、弾力、明るさ、赤み、なめらかさ、すべすべ感、ひきしめ感等の肌状態が向上するとともに、使用時に混合しやすく、塗りやすく、垂れにくく、使用後に剥がしやすいものとすることができるため、使用者にとって取り扱いが容易となる。 In the present invention, it is preferable that the viscosity of the first agent is 100 mPa · s or more and the viscosity of the second agent is 20,000 mPa · s or less. More preferably, the viscosity of the first agent is 500 mPa · s or more and the viscosity of the second agent is 10,000 mPa · s or less, and more preferably the viscosity of the first agent is 1,000 mPa · s or more and The viscosity of the second agent is 5,000 mPa · s or less. By setting the viscosities of the first agent and the second agent within the above range, it is possible to achieve both the gelling ability of the effervescent skin external preparation and the effect of carbon dioxide on the skin in a well-balanced manner. In particular, as is clear from the examples described later, the skin condition such as moistness, elasticity, brightness, redness, smoothness, smoothness, and tightness of the skin is improved, and it is easy to mix, apply, and drip during use. Since it is difficult and can be easily peeled off after use, it is easy for the user to handle.
<皮膚外用剤>
本発明のキットを用いて製造される発泡性型皮膚外用剤は、用途や目的に応じ、第一剤、第二剤に含まれる成分に加え、その他有効成分、増粘剤、保湿剤、防腐剤、pH調整剤、油脂、香料、着色剤、酸化防止剤、防菌防かび剤、アルコール、非イオン界面活性剤、アニオン界面活性剤、カチオン界面活性剤、両性界面活性剤などの界面活性剤、無機塩、滑沢剤、溶剤等の、通常皮膚外用剤に使用される成分の一種以上を使用することができる。この場合、添加する成分は第一剤、第二剤いずれか一方の剤に使用することができるし、どちらの剤にも使用しても良い。
<External skin agent>
The effervescent skin external preparation produced using the kit of the present invention has other active ingredients, a thickener, a moisturizer, and an antiseptic in addition to the ingredients contained in the first agent and the second agent, depending on the use and purpose. Surfactants such as agents, pH regulators, fats and oils, fragrances, colorants, antioxidants, antibacterial and antifungal agents, alcohols, nonionic surfactants, anionic surfactants, cationic surfactants, amphoteric surfactants, etc. , Inorganic salts, lubricants, solvents, and more than one of the ingredients normally used for external skin preparations can be used. In this case, the component to be added can be used for either the first agent or the second agent, or may be used for either agent.
以下、本発明のキットを用いて製造される発泡性型皮膚外用剤に含有される、酸、炭酸ガス発生物質、ゲル化剤、増粘剤、多価アルコール以外の成分の代表的なものについて更に説明する。 Hereinafter, representative components other than acids, carbon dioxide generating substances, gelling agents, thickeners, and polyhydric alcohols contained in the effervescent skin external preparation produced by using the kit of the present invention will be described. Further explanation will be given.
本発明に使用される有効成分としては、特に限定されることなく、化粧品、外用医薬品、医薬部外品等に用いられる薬剤や植物等を目的に応じ使用することができる。代表的なものとして、例えば、グリチルリチン酸及びそれらの誘導体並びにそれらの塩、グリチルレチン酸及びそれらの誘導体並びにそれらの塩、メフェナム酸、フェニルブタゾン、インドメタシン、イブプロフェン、ケトプロフェン、アラントイン、グアイアズレン、パンテノール、アラントイン等の抗炎症剤、アスコルビン酸及びその誘導体並びにそれらの塩、システイン及びその誘導体並びにその塩、グラブリジン、グラブレン、リクイリチン、イソリクイリチン、プラセンタ、ハイドロキノン及びその誘導体、レゾルシン及びその誘導体、グルタチオン等の美白剤、イオウ、チアントロール等の抗脂漏剤、サリチル酸、オウバク抽出物等の殺菌剤、トコフェロール及びその誘導体、甘草、アロエ、茶葉等の植物成分、エストラジオール等のホルモン等が挙げられる。なお、植物成分を使用する場合は、その全草、葉(葉身、葉柄等)、果実(成熟、未熟等)、種子、花(花弁、子房等)、茎、根茎、根、塊根等を、そのまま、切断、破砕、粉砕、搾取、抽出して用いるか、又はこれら処理されたものを乾燥若しくは粉末化して用いることができる。本発明に使用される有効成分は、第一剤、第二剤のいずれにも使用することができる。 The active ingredient used in the present invention is not particularly limited, and drugs, plants and the like used in cosmetics, external medicines, quasi-drugs and the like can be used depending on the purpose. Representative examples include glycyrrhizic acid and its derivatives and their salts, glycyrrhizic acid and its derivatives and their salts, mephenamic acid, phenylbutazone, indomethacin, ibprofen, ketoprofen, allantin, guaiazlen, pantenol, etc. Anti-inflammatory agents such as allantin, ascorbic acid and its derivatives and their salts, cysteine and its derivatives and their salts, glabridin, glabrene, liquoritin, isoliquilithin, placenta, hydroquinone and its derivatives, resorcin and its derivatives, glutathione and other whitening agents , Anti-fat leaking agents such as sulfur and thiantolol, bactericidal agents such as salicylic acid and Oubaku extract, tocopherols and their derivatives, plant components such as licorice, aloe and tea leaves, hormones such as estradiol and the like. When using plant components, the whole plant, leaves (leaf blades, petioles, etc.), fruits (mature, immature, etc.), seeds, flowers (petals, ovary, etc.), stems, rhizomes, roots, bulbs, etc. Can be used as it is by cutting, crushing, crushing, squeezing and extracting, or dried or powdered from these treated products. The active ingredient used in the present invention can be used for both the first agent and the second agent.
本発明において抽出物を用いる場合、抽出に用いる溶媒としては、例えば、水;メタノール、エタノール、プロパノール、ブタノール、エチレングリコール、プロピレングリコール、1,3−ブチレングリコール、ジエチレングリコール、ジプロピレングリコール、へキシレングリコール、グリセリン、酢酸メチル、酢酸エチル、酢酸イソプロピル、エチルエーテル、アセトンなどの有機溶媒を挙げることができる。これらは1種又は2種以上組み合わせて用いることができる。安全性等の点から、人体に無害な水、エタノール、1,3−ブチレングリコール、又はこれらの混合溶媒を抽出溶媒として用いることが好ましい。抽出は抽出溶媒の沸点以下であればよく、抽出温度によって適宜抽出時間は変更することができる。 When the extract is used in the present invention, the solvent used for the extraction is, for example, water; methanol, ethanol, propanol, butanol, ethylene glycol, propylene glycol, 1,3-butylene glycol, diethylene glycol, dipropylene glycol, hexylene glycol. , Glycerin, methyl acetate, ethyl acetate, isopropyl acetate, ethyl ether, acetone and other organic solvents can be mentioned. These can be used alone or in combination of two or more. From the viewpoint of safety and the like, it is preferable to use water, ethanol, 1,3-butylene glycol, or a mixed solvent thereof, which are harmless to the human body, as the extraction solvent. The extraction may be performed as long as it is below the boiling point of the extraction solvent, and the extraction time can be appropriately changed depending on the extraction temperature.
本発明に使用される増粘剤としては、化粧品、外用医薬品、医薬部外品等で使用できる水溶性成分であれば特に限定されるものでなく、合成高分子、半合成高分子、天然高分子、粘度鉱物等が使用できる。増粘剤は第一剤、第二剤のどちらにも使用できるが、第一剤に使用することが好ましい。 The thickener used in the present invention is not particularly limited as long as it is a water-soluble component that can be used in cosmetics, external medicines, quasi-drugs, etc. Polymers, viscous minerals, etc. can be used. The thickener can be used as either the first agent or the second agent, but it is preferably used as the first agent.
合成高分子としては、カルボキシビニルポリマー、ポリビニルアルコール、アクリル酸・メタクリル酸アルキル共重合体、アクリレーツ/アクリル酸アルキルクロスポリマー、ポリアクリル酸、ポリアクリルアミド、ポリアルキルアクリルアミド/ポリアクリルアミドコポリマー、カルボキシメチルセルロース、カチオン化セルロース、プルロニックをはじめとする親水性合成高分子が挙げられる。 Synthetic polymers include carboxyvinyl polymers, polyvinyl alcohol, acrylic acid / alkyl methacrylate copolymers, acrylic acid / alkyl acrylate cross polymers, polyacrylic acid, polyacrylamide, polyalkylacrylamide / polyacrylamide copolymers, carboxymethyl cellulose, cations. Examples thereof include hydrophilic synthetic polymers such as acrylamide and Pluronic.
半合成高分子としては、セルロース誘導体としては例えば、カルボキシメチルセルロース又はその塩類、メチルセルロース、エチルセルロース、プロピルセルロース、ヒドロキシメチルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルメチルセルロース、スルホン化セルロース誘導体などが挙げられる。その他の半合成高分子として、アルギン酸プロピレングリコールエステル、アルギン酸エチレングリコールエステル、デキストリン脂肪酸エステル、ゼラチン脂肪酸エステル、ゼラチン脂肪酸アミドなどが挙げられる。 Examples of the semi-synthetic polymer include carboxymethyl cellulose or salts thereof, propyl cellulose, hydroxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl methyl cellulose, sulfonated cellulose derivative and the like. Other semi-synthetic polymers include propylene glycol alginate, ethylene glycol alginate, dextrin fatty acid ester, gelatin fatty acid ester, gelatin fatty acid amide and the like.
天然高分子としては、多糖類及びその誘導体、例えば、キサンタンガム、サクシノグリカン、カラギーナン、グアーガム、ローカストビーンガム、セルロース類、ガラクタン、アラビアガム、トラガントガム、寒天、アガロース、マンナン、カードラン、アルギン酸又はその塩類、アラビアゴム、ペクチン、クインシード、デンプン、アルゲコロイド、コンドロイチン硫酸又はその塩類、キトサン及びその誘導体などが挙げられる。その他の天然高分子としては、核酸又はその塩類、リボ核酸又はその塩類、カゼイン、コラーゲン、ゼラチン、アルブミン、フィブロイン、エラスチン、ケラチン、セリシン等の水溶性タンパク質、ヒアルロン酸又はその塩、コンドロイチン硫酸などのムコ多糖類などが挙げられる。 Natural polymers include polysaccharides and their derivatives such as xanthan gum, succinoglycan, carrageenan, guar gum, locust bean gum, celluloses, galactan, arabic gum, tragant gum, agar, agarose, mannan, curdlan, alginic acid or itss. Examples thereof include salts, gum arabic, pectin, quinceed, starch, algae colloid, chondroitin sulfate or salts thereof, chitosan and derivatives thereof. Other natural polymers include nucleic acids or salts thereof, ribonucleic acids or salts thereof, casein, collagen, gelatin, albumin, fibroin, elastin, keratin, sericin and other water-soluble proteins, hyaluronic acid or salts thereof, chondroitin sulfate and the like. Examples include mucopolysaccharide.
粘土鉱物としては、ラポナイト、ベントナイト、スメクタイトカオリナイト、モンモリロナイト等が挙げられる。 Examples of clay minerals include laponite, bentonite, smectite kaolinite, and montmorillonite.
以上の増粘剤のなかでも、溶解性又は分散性が高いものを用いることが、増粘剤のダマを生じず均一に溶解又は分散でき、且つ、未溶解成分や未分散成分に起因する肌のざらつき感を緩和することができるため好ましい。 Among the above thickeners, those having high solubility or dispersibility can be uniformly dissolved or dispersed without causing lumps in the thickener, and the skin caused by the undissolved component or the undispersed component. It is preferable because it can alleviate the feeling of roughness.
このような増粘剤としては、例えば、カルボキシビニルポリマー、カルボキシメチルセルロース又はその塩類、ポリビニルアルコール、ポリアクリル酸ソーダ、アクリル酸・メタクリル酸アルキル共重合体、キサンタンガム、サクシノグリカン、カラギーナン、グアーガム、ローカストビーンガム、セルロース類、ガラクタン、アラビアガム、トラガントガム、寒天、マンナン、カードラン、アルギン酸又はその塩類、コラーゲン、ゼラチン、アルブミン等を挙げる事ができ、カルボキシメチルセルロース又はその塩類、キサンタンガム、カラギーナン、アルブミンを用いることが好ましい。前記増粘剤は1種又は2種以上を使用できる。 Examples of such thickeners include carboxyvinyl polymers, carboxymethyl cellulose or salts thereof, polyvinyl alcohol, sodium polyacrylic acid, alginic acid / alkyl methacrylate copolymers, xanthan gum, succinoglycans, carrageenan, guar gum, and locusts. Bean gum, celluloses, galactan, arabic gum, tragant gum, agar, mannan, curdran, alginic acid or its salts, collagen, gelatin, albumin and the like can be mentioned, and carboxymethyl cellulose or its salts, xanthan gum, carrageenan and albumin are used. Is preferable. The thickener may be used alone or in combination of two or more.
本発明に使用される界面活性剤としては、非イオン界面活性剤、アニオン界面活性剤、カチオン界面活性剤、両性界面活性剤が挙げられる。界面活性剤は合成界面活性剤、天然界面活性剤のいずれも使用できるが、皮膚への安全性の観点から、天然界面活性剤が好ましい。ここで言う天然界面活性剤とは、主に動物または植物の由来の界面活性効果を有する物質のことを言い、具体例としては、レシチンなどのリン脂質、糖脂質、ラノリン、コレステロール、サポニン、セラミドなどのスフィンゴ脂質、ペクチン、グリチルリチン酸塩、胆汁酸、植物抽出アミノ酸系界面活性剤等が挙げられる。その中でも、リン脂質、サポニン、スフィンゴ脂質、ペクチン、グリチルリチン酸塩を含む抽出物を含有していることが好ましく、サポニンを含む抽出物を含有していることが特に好ましい。サポニンを含む抽出物としては、植物由来の抽出物を用いることが好ましい。サポニンを含む植物の例としては、ダイズ、アズキ、インゲン、ホウレンソウ、サトウダイコン、ブドウ、キキョウ、甘草、セネガ、キラヤ、ムクロジ、サボンソウ、オタネニンジン、ヘチマ、茶種子、エンジュ、ユリ科植物や、ヤマノイモ科植物、チモ(知母)、バクモンドウ(麦門冬)などを挙げることができる。本発明においては、サポニンを含む抽出物として、これら植物のうち、ダイズ、アズキ、甘草、ムクロジ、ヘチマから選ばれる1種以上の植物の抽出物を含有することが好ましく、とりわけ、ムクロジの抽出物を含有することが好ましい。 Examples of the surfactant used in the present invention include nonionic surfactants, anionic surfactants, cationic surfactants, and amphoteric surfactants. As the surfactant, either a synthetic surfactant or a natural surfactant can be used, but from the viewpoint of skin safety, the natural surfactant is preferable. The term "natural surfactant" as used herein refers to a substance having a surface-active effect mainly derived from animals or plants, and specific examples thereof include phospholipids such as lecithin, glycolipids, lanolin, cholesterol, saponin, and ceramide. Examples thereof include sphingolipids such as pectin, glycyrrhizinate, bile acids, and plant-extracted amino acid-based surfactants. Among them, it is preferable to contain an extract containing phospholipid, saponin, sphingolipid, pectin, and glycyrrhizate, and it is particularly preferable to contain an extract containing saponin. As the extract containing saponin, it is preferable to use a plant-derived extract. Examples of plants containing saponin include soybean, azuki, green bean, spinach, sugar cane, grape, kikyo, licorice, senega, kiraya, mukuroji, saponin, otane carrot, hechima, tea seed, enju, liliaceae, and yam. Plants, chimo (common bean), Bakumondou (wheat gate winter), etc. can be mentioned. In the present invention, as an extract containing saponin, it is preferable to contain an extract of one or more plants selected from soybean, adzuki bean, licorice, Sapindaceae, and loofah among these plants, and in particular, an extract of Sapindaceae. Is preferably contained.
前記天然界面活性剤は増粘剤と併用することで気泡をより長く保つことができる。 The natural surfactant can be used in combination with a thickener to keep bubbles longer.
<発泡性皮膚外用剤の使用形態>
本発明のキットは、発泡性皮膚外用剤を得るための使用に際し、第一剤と第二剤を適量容器内で混合することにより炭酸ガスによる発泡を生じさせる。第一剤と第二剤は1:0.1〜1:30の割合で混合することが好ましく、1:0.5〜1:10の割合で混合することがより好ましい。
<Usage form of effervescent skin external preparation>
When used to obtain an effervescent skin external preparation, the kit of the present invention causes effervescence by carbon dioxide gas by mixing an appropriate amount of the first agent and the second agent in a container. The first agent and the second agent are preferably mixed at a ratio of 1: 0.1 to 1:30, and more preferably at a ratio of 1: 0.5 to 1:10.
本発明のキットを保存する方法としては、化粧品、外用医薬品、医薬部外品等を保存する方法を用いることができ、特に制限はない。使用される保存容器の形状は、目的に応じて適宜選択でき、カップ状、チューブ状、バッグ状、瓶状、スティック状、ポンプ状、ジャー状、缶詰状等が挙げられる。また、保存容器を構成する材料は、例えば、プラスチック、ガラス、アルミニウム、紙、各種ポリマー等を単独あるいは2種以上選択して用いることができるが、これらに限定されない。 As a method for storing the kit of the present invention, a method for storing cosmetics, external medicines, quasi-drugs and the like can be used, and there is no particular limitation. The shape of the storage container to be used can be appropriately selected depending on the intended purpose, and examples thereof include a cup shape, a tube shape, a bag shape, a bottle shape, a stick shape, a pump shape, a jar shape, and a canned shape. Further, as the material constituting the storage container, for example, plastic, glass, aluminum, paper, various polymers and the like can be used alone or by selecting two or more kinds, but the material is not limited thereto.
容器の具体例としては、密閉性、内容物の保存安定性、製造コスト等の点で、内面をポリエチレンテレフタレートでラミネートしたアルミスティック、アルミバッグ等の保存容器、チャック付きスタンドパウチ、内面をポリエチレンテレフタレートでラミネートしたアルミフィルム等で蓋をヒートシールしたポリエチレンテレフタレート製の保存容器等が好ましい。 Specific examples of the container include an aluminum stick whose inner surface is laminated with polyethylene terephthalate, a storage container such as an aluminum bag, a stand pouch with a chuck, and a polyethylene terephthalate inner surface in terms of airtightness, storage stability of contents, manufacturing cost, and the like. A storage container made of polyethylene terephthalate whose lid is heat-sealed with an aluminum film or the like laminated with the above is preferable.
<発泡性皮膚外用剤の用途>
本発明のキットを使用して得られる発泡性皮膚外用剤は、皮膚血流量の増加を促すものであり、美白、肌質改善、そばかす改善、肌の若返り、肌の引き締め、部分痩せ、皮膚を清浄にする、肌を整える、肌のキメを整える、皮膚をすこやかに保つ、肌荒れを防ぐ、肌をひきしめる、皮膚にうるおいを与える、皮膚の水分,油分を補い保つ、皮膚の柔軟性を保つ、皮膚を保護する、皮膚に乾燥を防ぐ、肌を柔らげる、肌にはりを与える、肌にツヤを与える、肌を滑らかにする、日やけによるシミ・ソバカスを防ぐ、乾燥による小ジワを目立たなくすることを目的とした化粧品だけでなく、肌あれ、あれ性、あせも・しもやけ・ひび・あかぎれ・にきびの予防、油症肌、かみそりまけの予防、日やけによるしみ・そばかすの予防、日やけ・雪やけ後のほてりを防ぐ、肌をひきしめる、肌を清浄にする、肌を整える、皮膚をすこやかに保つ、皮膚にうるおいを与える、皮膚を保護する、皮膚の乾燥を防ぐ等を目的とした、化粧品、医薬部外品、薬品等の医薬品のいずれにも好適に使用することができる。本発明の皮膚外用剤は、化粧品、医薬部外品としての使用が好ましく、乳液、クリーム、パック剤、ピーリング剤等の化粧品、薬用化粧品としての使用がより好ましい。特にその中でもパック剤として使用すると、使用感がよく、短時間で高い肌状態改善効果が得やすいため好ましい。
<Use of effervescent skin external preparation>
The effervescent skin external preparation obtained by using the kit of the present invention promotes an increase in skin blood flow, and whitens, improves skin quality, improves freckles, rejuvenates the skin, tightens the skin, partially thins the skin, and relieves the skin. Cleanse, condition the skin, condition the skin, keep the skin healthy, prevent rough skin, tighten the skin, moisturize the skin, keep the skin moisturized and oily, keep the skin soft, Protects the skin, prevents the skin from drying out, softens the skin, gives the skin a suppleness, gives the skin a gloss, smoothes the skin, prevents stains and buckwheat caused by sunburn, and notices fine wrinkles due to dryness. Not only cosmetics aimed at eliminating, but also rough skin, rough skin, rash, rash, cracks, cracks, acne prevention, oily skin, prevention of shavings, prevention of sunburn stains and freckles, sunburn・ The purpose is to prevent burning after snow burning, to tighten the skin, to clean the skin, to condition the skin, to keep the skin healthy, to moisturize the skin, to protect the skin, to prevent the skin from drying out, etc. , Cosmetics, non-pharmaceutical products, pharmaceuticals and other pharmaceutical products can be suitably used. The external skin preparation of the present invention is preferably used as cosmetics and quasi-drugs, and more preferably used as cosmetics such as milky lotions, creams, packs and peeling agents, and medicated cosmetics. In particular, it is preferable to use it as a facial mask because it has a good feeling of use and a high skin condition improving effect can be easily obtained in a short time.
本発明のキットを用いて得られた発泡性皮膚外用剤をパック剤として使用する場合、所望の部位を覆うように0.2mm以上、好ましくは0.5mm以上の厚さに塗布すればよい。0.2mm以上の厚さに塗布することで、炭酸ガスによる肌状態改善効果を得ることができる。また、使用時間は1分以上であれば良く、好ましくは3分以上、より好ましくは5分以上である。塗布終了後は拭き取るか、水などで洗い流すか、あるいはその両方を行ってもよい。 When the effervescent skin external preparation obtained by using the kit of the present invention is used as a pack agent, it may be applied to a thickness of 0.2 mm or more, preferably 0.5 mm or more so as to cover a desired site. By applying to a thickness of 0.2 mm or more, the effect of improving the skin condition by carbon dioxide can be obtained. The usage time may be 1 minute or longer, preferably 3 minutes or longer, and more preferably 5 minutes or longer. After the application is completed, it may be wiped off, rinsed with water or the like, or both.
以下、実施例を示して本発明を更に具体的に説明するが、本発明の範囲は、これらの実施例に限定されるものではない。下記の各実施例及び参考例において、使用する原料は特にことわりのない限り、市販品を用いた。 Hereinafter, the present invention will be described in more detail with reference to examples, but the scope of the present invention is not limited to these examples. In each of the following Examples and Reference Examples, commercially available raw materials were used unless otherwise specified.
<発泡性皮膚外用剤の製造>
表1に示した組成に従い、本発明のキットを製造した。
<Manufacturing of effervescent skin external preparation>
The kit of the present invention was produced according to the composition shown in Table 1.
実施例1〜8、参考例1〜3
[第一剤]
ビーカーに精製水を加え、次いで第一剤に記載の原料を加えて撹拌し、第一剤を得た。
[第二剤]
ビーカーに精製水を加え、次いで第二剤に記載の原料を加えて撹拌し、第二剤を得た。
Examples 1-8, Reference Examples 1-3
[First agent]
Purified water was added to the beaker, then the raw materials described in the first agent were added and stirred to obtain the first agent.
[Second agent]
Purified water was added to the beaker, then the raw material described in the second agent was added and stirred to obtain the second agent.
<発泡性皮膚外用剤の特性評価>
下記要領に従い、前記実施例1〜3及び参考例1〜3で得られた発泡性皮膚外用剤の特性を評価した。
[評価例1.第二剤粘度の評価]
表1に記載の第二剤において、粘度計(ブルックフィールド社製 RVT型)を用いて、25℃における実施例1〜8、参考例1〜3の粘度を測定した。第一剤の粘度結果を表2に、第二剤の粘度測定結果を表3に示す。
<Characteristic evaluation of effervescent skin external preparation>
The characteristics of the effervescent skin external preparations obtained in Examples 1 to 3 and Reference Examples 1 to 3 were evaluated according to the following procedure.
[Evaluation example 1. Evaluation of second agent viscosity]
In the second agent shown in Table 1, the viscosities of Examples 1 to 8 and Reference Examples 1 to 3 at 25 ° C. were measured using a viscometer (RVT type manufactured by Brookfield). Table 2 shows the viscosity results of the first agent, and Table 3 shows the viscosity measurement results of the second agent.
[評価例2.使用前後の肌状態測定]
前記実施例1〜8、参考例1〜3で得られた本発明のキットを用いて発泡性皮膚外用剤を調製し、得られた発泡性皮膚外用剤の使用前後における角層水分量(測定機器:SKICON―200EX)、水分蒸散量(測定機器:TewameterTM300)、色差(測定機器:色彩色差計)及び弾力(測定機器:Cutometer MPA580)を測定した。
被験者(30代女性2名)の前腕内側を洗顔料で洗浄し測定室で15分間安静に過ごした。次に、発泡性皮膚外用剤使用前の測定を行った。次に、測定部位に、第一剤:第二剤を2:1で混合した前記発泡性皮膚外用剤を塗布し、10分間静置した。次に、発泡性皮膚外用剤を除去し、軽く水で湿らせた布で拭き取った。洗浄後15分経過してから発泡性皮膚外用剤使用後の測定を行った。尚、被験者は測定中、測定室にて安静に過ごした。
使用後の肌状態測定結果を表4に示す。表4は角層水分量、水分蒸散量、色差及び弾力の測定結果である。表4はそれぞれ発泡性皮膚外用剤使用前を1とした比較値を表す。角層水分量は数値が大きいほど肌が潤っていて良いことを示し、水分蒸散量は数値が小さいほどバリア機能が整っていて良い結果であることを示し、色差は数値が大きいほど色が白くなったことを示し、弾力は数値が大きいほど肌のハリがあって良いことを示す。
[Evaluation example 2. Skin condition measurement before and after use]
Effervescent skin external preparations were prepared using the kits of the present invention obtained in Examples 1 to 8 and Reference Examples 1 to 3, and the water content of the stratum corneum (measurement) before and after the use of the obtained effervescent skin external preparations. Equipment: SKION-200EX), water evaporation amount (measurement equipment: TewameterTM300), color difference (measurement equipment: color difference meter) and elasticity (measurement equipment: Cutometer MPA580) were measured.
The inside of the forearm of the subjects (two females in their thirties) was washed with a cleanser and rested for 15 minutes in the measurement room. Next, the measurement before using the effervescent skin external preparation was performed. Next, the effervescent skin external preparation, which was a 2: 1 mixture of the first agent and the second agent, was applied to the measurement site and allowed to stand for 10 minutes. Next, the effervescent external skin preparation was removed and wiped off with a lightly moistened cloth. After 15 minutes had passed after washing, the measurement was performed after using the effervescent skin external preparation. The subject spent a rest in the measurement room during the measurement.
Table 4 shows the results of skin condition measurement after use. Table 4 shows the measurement results of the water content of the stratum corneum, the water evaporation amount, the color difference and the elasticity. Table 4 shows the comparative values with 1 before the use of the effervescent skin external preparation. The larger the value, the better the skin is moisturized, the smaller the value, the better the barrier function, and the larger the value, the whiter the color. It indicates that the skin has become firmer, and the larger the value, the better the elasticity of the skin.
[評価例3.発泡性皮膚外用剤の使用感の評価]
前記実施例1〜8、参考例1〜3で得られた本発明のキットを用いて発泡性皮膚外用剤を調製し、得られた発泡性皮膚外用剤の使用時、及び使用後について、表5、表6に示す項目の評価を行った。
まず、被験者(30代女性2名)の前腕内側を洗顔料で洗浄し、15分間安静に過ごした。次に、測定部位に、第一剤:第二剤を2:1で混合した前記発泡性皮膚外用剤を塗布し、10分間静置した。次に、発泡性皮膚外用剤を除去し、軽く水で湿らせた布で拭き取った。その後、表5の8項目、表6の7項目についてアンケートを実施した。アンケートの評価は、下記の項目について、1(とても悪い)〜7(とても良い)の7段階で評価し、平均点を算出した。尚、被験者は測定中、測定室にて安静に過ごした。
[Evaluation example 3. Evaluation of usability of effervescent skin external preparation]
Effervescent skin external preparations were prepared using the kits of the present invention obtained in Examples 1 to 8 and Reference Examples 1 to 3, and the table shows the time and after use of the obtained effervescent skin external preparations. 5. The items shown in Table 6 were evaluated.
First, the inside of the forearm of the subjects (two females in their thirties) was washed with a cleanser and spent 15 minutes at rest. Next, the effervescent skin external preparation, which was a 2: 1 mixture of the first agent and the second agent, was applied to the measurement site and allowed to stand for 10 minutes. Next, the effervescent external skin preparation was removed and wiped off with a lightly moistened cloth. After that, questionnaires were conducted on 8 items in Table 5 and 7 items in Table 6. The questionnaire was evaluated on a scale of 1 (very bad) to 7 (very good) for the following items, and the average score was calculated. The subject spent a rest in the measurement room during the measurement.
表2より、実施例1〜8は第一剤の粘度が500mPa・s以上、かつ、第二剤の粘度が20,000mPa・s以下である。一方、参考例1、2は第一剤の粘度が500mPa・s以上であるが、第二剤の粘度が20,000mPa・s以上であり、参考例3は第一剤の粘度が500mPa・s以下、かつ、第二剤の粘度が20,000mPa・s以下あることがわかる。
表4より、使用後の肌の状態は、角層水分量は実施例7>実施例5>実施例8>実施例6>実施例3>実施例4>実施例2>実施例1>参考例1>参考例2>参考例3の順でよい結果が得られ、水分蒸散量は実施例7>実施例3>実施例5>実施例4>実施例2>実施例6>実施例8>実施例1>参考例3>参考例2>参考例1の順でよい結果が得られ、色差は実施例6>実施例8>実施例7>実施例5>実施例4>実施例3>実施例2>実施例1>参考例2>参考例1>参考例3の順でよい結果が得られ、弾力は実施例6>実施例8>実施例4>実施例5>実施例7>実施例3>実施例1>実施例2>参考例1>参考例3>参考例2の順でよい結果が得られた。すなわち、参考例1〜3に比べて実施例1〜8は使用後の状態向上に効果があることがわかり、特に第二剤に多価アルコールを2種類以上配合する実施例3〜8でその効果が高くなる、すなわち、肌をみずみずしく保ち、バリア機能が整い、色が白くハリのある肌となるとがわかる。
また、表5より、本発明のキットを用いて得られた発泡性皮膚外用剤は参考例1〜3と比べて使用時の評価が高いことがわかる。特に、第一剤と第二剤の混合時に混ぜやすく、混合後に塗りやすく、垂れにくく、使用後に剥がしやすいことがわかる。
また、表6より、使用後の肌のしっとり感、弾力、肌が明るくなる、肌の赤み、肌のなめらかさ、すべすべ感、ひきしめ感が確認できる効果が得られているため、使用者にとって容易に使用しやすく、かつ、肌への効果が高いことがわかる。
以上の結果より、本発明のキットを用いて得られた発泡性皮膚外用剤は、使用者にとって容易に使用しやすく、かつ、肌への効果が高いことがわかる。
From Table 2, in Examples 1 to 8, the viscosity of the first agent is 500 mPa · s or more, and the viscosity of the second agent is 20,000 mPa · s or less. On the other hand, in Reference Examples 1 and 2, the viscosity of the first agent is 500 mPa · s or more, but the viscosity of the second agent is 20,000 mPa · s or more, and in Reference Example 3, the viscosity of the first agent is 500 mPa · s. Below, it can be seen that the viscosity of the second agent is 20,000 mPa · s or less.
From Table 4, the skin condition after use is as follows: Example 7> Example 5> Example 8> Example 6> Example 3> Example 4> Example 2> Example 1> Reference Good results were obtained in the order of Example 1> Reference Example 2> Reference Example 3, and the amount of water evaporation was Example 7> Example 3> Example 5> Example 4> Example 2> Example 6> Example 8. > Example 1> Reference Example 3> Reference Example 2> Reference Example 1 gives good results, and the color difference is Example 6> Example 8> Example 7> Example 5> Example 4> Example 3. > Example 2> Example 1> Reference Example 2> Reference Example 1> Reference Example 3 in this order, good results were obtained, and the elasticity was shown in Example 6> Example 8> Example 4> Example 5> Example 7. Good results were obtained in the order of> Example 3> Example 1> Example 2> Reference Example 1> Reference Example 3> Reference Example 2. That is, it was found that Examples 1 to 8 are more effective in improving the condition after use than Reference Examples 1 to 3, and in particular, Examples 3 to 8 in which two or more kinds of polyhydric alcohols are mixed with the second agent are described. It can be seen that the effect is high, that is, the skin is kept fresh, the barrier function is set, and the skin becomes white and firm.
Further, from Table 5, it can be seen that the effervescent skin external preparation obtained by using the kit of the present invention is highly evaluated at the time of use as compared with Reference Examples 1 to 3. In particular, it can be seen that it is easy to mix when mixing the first agent and the second agent, it is easy to apply after mixing, it is hard to drip, and it is easy to peel off after use.
In addition, from Table 6, it is easy for the user to confirm the moist feeling, elasticity, brightening of the skin, redness of the skin, smoothness of the skin, smoothness, and tightness after use. It can be seen that it is easy to use and has a high effect on the skin.
From the above results, it can be seen that the effervescent skin external preparation obtained by using the kit of the present invention is easy for the user to use and has a high effect on the skin.
以下に、本発明のキットの具体的な処方例を示す。第一剤、第二剤とも実施例1の製法と同様の製法又は一般的な化粧品の製法にて製造することができる。 Specific prescription examples of the kit of the present invention are shown below. Both the first agent and the second agent can be produced by the same production method as that of Example 1 or by a general cosmetic production method.
実施例9 Example 9
表7に記載の処方にて、実施例1と同様の方法で発泡性皮膚外用剤用キットを調整した。得られたキットの第一剤と第二剤を1:1で混合すると、発泡性皮膚外用剤を得ることができる。 The effervescent skin external preparation kit was prepared in the same manner as in Example 1 according to the formulations shown in Table 7. The effervescent skin external preparation can be obtained by mixing the first agent and the second agent of the obtained kit in a ratio of 1: 1.
実施例10 Example 10
表8に記載の処方にて、実施例1と同様の方法で発泡性皮膚外用剤用キットを調整した。得られたキットの第一剤と第二剤を3:1で混合すると、発泡性皮膚外用剤を得ることができる。 The effervescent skin external preparation kit was prepared in the same manner as in Example 1 according to the formulations shown in Table 8. By mixing the first agent and the second agent of the obtained kit in a ratio of 3: 1, an effervescent skin external preparation can be obtained.
実施例11 Example 11
表9に記載の処方にて、実施例1と同様の方法で発泡性皮膚外用剤用キットを調整した。得られたキットの第一剤と第二剤を1:1で混合すると、発泡性皮膚外用剤を得ることができる。 The effervescent skin external preparation kit was prepared in the same manner as in Example 1 according to the formulations shown in Table 9. The effervescent skin external preparation can be obtained by mixing the first agent and the second agent of the obtained kit in a ratio of 1: 1.
実施例12 Example 12
表10に記載の処方にて、実施例1と同様の方法で発泡性皮膚外用剤用キットを調整した。得られたキットの第一剤と第二剤を2:1で混合すると、発泡性皮膚外用剤を得ることができる。 The effervescent skin external preparation kit was prepared in the same manner as in Example 1 according to the formulations shown in Table 10. The effervescent skin external preparation can be obtained by mixing the first agent and the second agent of the obtained kit in a ratio of 2: 1.
前記検討から明らかなように、本発明のキットは、均一に混合することが容易であり、使用時に炭酸ガスがムラなく発生するという効果を奏する。更に、本発明のキットを用いて得られた発泡性皮膚外用剤を用いることで、肌をみずみずしく保ち、バリア機能が整い、色が白くハリのある肌が得られるという効果を奏することがわかる。 As is clear from the above studies, the kit of the present invention is easy to mix uniformly, and has the effect of evenly generating carbon dioxide gas during use. Furthermore, it can be seen that the use of the effervescent skin external preparation obtained by using the kit of the present invention has the effect of keeping the skin fresh, having a barrier function, and obtaining white and firm skin.
Claims (1)
(A)第一剤が炭酸ガス発生物質、ゲル化剤及び水を含有する組成物であり、第二剤が酸、水及び多価アルコールを含有し、増粘剤を含有しない液状の組成物。
(B)第一剤が酸、ゲル化剤及び水を含有する組成物であり、第二剤が炭酸ガス発生物質、水及び多価アルコールを含有し、増粘剤を含有しない液状の組成物。
A kit for obtaining an effervescent skin external preparation, which contains a carbon dioxide gas generating substance, an acid, a gelling agent, a polyhydric alcohol and water, and has a viscosity of the first agent of 5200 to 430300 mPa · s, and a second agent. A kit characterized in that the viscosity of the agent is 2740 mPa · s or less in either form (A) or (B).
(A) The first agent is a composition containing a carbon dioxide generating substance, a gelling agent and water, and the second agent is a liquid composition containing an acid, water and a polyhydric alcohol and not containing a thickener. ..
(B) The first agent is a composition containing an acid, a gelling agent and water, and the second agent is a liquid composition containing a carbon dioxide gas generating substance, water and a polyhydric alcohol and not containing a thickener. ..
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020024518A JP6985752B2 (en) | 2015-08-28 | 2020-02-17 | Kit for external skin preparation |
| JP2021187455A JP7157488B2 (en) | 2015-08-28 | 2021-11-18 | Kits for topical skin preparations |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015169704A JP6681056B2 (en) | 2015-08-28 | 2015-08-28 | External skin preparation kit |
| JP2020024518A JP6985752B2 (en) | 2015-08-28 | 2020-02-17 | Kit for external skin preparation |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015169704A Division JP6681056B2 (en) | 2015-08-28 | 2015-08-28 | External skin preparation kit |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021187455A Division JP7157488B2 (en) | 2015-08-28 | 2021-11-18 | Kits for topical skin preparations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020090540A JP2020090540A (en) | 2020-06-11 |
| JP6985752B2 true JP6985752B2 (en) | 2021-12-22 |
Family
ID=79193124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020024518A Active JP6985752B2 (en) | 2015-08-28 | 2020-02-17 | Kit for external skin preparation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6985752B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022189370A (en) * | 2021-06-11 | 2022-12-22 | 株式会社コーセー | Composition for enhancing bound water in horny layer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5159967B1 (en) * | 2011-08-31 | 2013-03-13 | 株式会社ミリオナ化粧品 | Packing agent |
| JP5564130B1 (en) * | 2013-03-18 | 2014-07-30 | 株式会社みやびコスメティックス | Foam type external preparation for skin |
| JP6343793B2 (en) * | 2013-03-25 | 2018-06-20 | 忠洋 嶋田 | Effervescent cosmetics |
| JP5692618B1 (en) * | 2014-05-12 | 2015-04-01 | 株式会社東洋新薬 | Skin preparation kit |
| JP2016008181A (en) * | 2014-06-23 | 2016-01-18 | 株式会社東洋新薬 | Kit for skin external preparation |
| JP6108363B2 (en) * | 2015-02-04 | 2017-04-05 | 株式会社東洋新薬 | Skin preparation kit |
-
2020
- 2020-02-17 JP JP2020024518A patent/JP6985752B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2020090540A (en) | 2020-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6681056B2 (en) | External skin preparation kit | |
| JP2016008181A (en) | Kit for skin external preparation | |
| JP7442222B1 (en) | Skin external preparations | |
| JP2022000465A (en) | Foamable skin external preparation | |
| JP7818814B2 (en) | Foaming skin topical preparation kit | |
| KR20140055689A (en) | Gommage type cosmetic compostion for exfoliating skin having low irritant | |
| JP5692618B1 (en) | Skin preparation kit | |
| JP6985752B2 (en) | Kit for external skin preparation | |
| JP6424356B2 (en) | Effervescent skin external preparation | |
| JP6851646B2 (en) | Kit for external preparations for skin | |
| KR20140130830A (en) | Cleansing agent composition including natural compounds and method for manufacturing the same | |
| JP2022028825A (en) | Kit for external skin preparation | |
| JP6648230B2 (en) | Skin preparation kit | |
| JP3479048B2 (en) | Cosmetics and non-woven fabric impregnated cosmetics | |
| JP6181686B2 (en) | Effervescent skin preparation | |
| JP2022020844A (en) | Foamable external preparation for skin | |
| JP2021116306A (en) | Oil-based composition | |
| JP7357891B2 (en) | Foaming skin topical preparation | |
| JP6906788B2 (en) | Hair growth composition | |
| JP6628197B2 (en) | Skin preparation kit | |
| JP6424355B2 (en) | Skin external preparation kit | |
| JP2025077507A (en) | Foaming skin care product | |
| JP7553274B2 (en) | Aerosol composition for disinfection | |
| JP2008195638A (en) | Kit for skin treatment | |
| JP2009190986A (en) | Transparent gel cosmetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200226 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210329 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210527 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20211025 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20211118 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6985752 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |